BioSpace News Archive

According to QY Research Medical, the endovascular aneurysm repair market size is projected to surpass US$ 4,359.20 million by 2030 and growing at a registered CAGR of 5 % from 2021 to 2030.

Company’s web-based platform empowers researchers to integrate, process, and visualize biological data in one place, shortening timelines from experiment to results.

The India IVF services market size was valued at $793.27 Million in 2020 and is projected to reach $3,721.99 Million by 2030 registering a CAGR of 16.45% from 2021 to 2030.

Researchers from Children’s Hospital of Philadelphia found that while autism screening rates during the first year of the COVID-19 pandemic may not have dropped sharply, many routine screenings may have been missed due to routine well-child visits being canceled and postponed.

The global medical device coating market was estimated at $7,280 million in 2020 and is expected to reach $12,705 million by 2030, registering a CAGR of 6.8% from 2021 to 2030.

According to QY Research Medical, the medical imaging informatics market size was accounted at $2.6 billion in 2020, and is expected to reach $4.8 billion by 2030, growing at a CAGR of 6.5% from 2021 to 2030.

G1 Therapeutics, Inc. (Nasdaq: GTHX), today announced results of a post-hoc study analysis showing that ES-SCLC patients who received trilaciclib prior to chemotherapy had a lower incidence of single- and multilineage myelosuppressive events—fewer cases of severe neutropenia, severe anemia, and severe thrombocytopenia—compared to patients receiving placebo.

According to QY Research Medical, the refurbished DNA sequencing platforms market size was estimated at $89.83 million in 2020, and is expected to reach $129.61 million by 2030, registering a CAGR of 2.6% from 2021 to 2030.

Evolus, Inc., a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced that Dermatologic Surgery published a new post hoc analysis of its Phase III studies comparing millennial patients to non-millennials.

Neurophth Therapeutics, Inc., announced the appointment of Xiaoning Guo, Ph.D., as the Chief Medical Officer.